Nordea Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $494M | Buy |
|
|||||
|
2025
Q2 | $437M | Buy |
|
|||||
|
2025
Q1 | $317M | Buy |
|
|||||
|
2024
Q4 | $71.1M | Buy |
|
|||||
|
2024
Q3 | $61M | Sell |
|
|||||
|
2024
Q2 | $67.9M | Sell |
|
|||||
|
2024
Q1 | $76.2M | Sell |
|
|||||
|
2023
Q4 | $91.1M | Buy |
|
|||||
|
2023
Q3 | $55.8M | Sell |
|
|||||
|
2023
Q2 | $57.5M | Sell |
|
|||||
|
2023
Q1 | $65.1M | Sell |
|
|||||
|
2022
Q4 | $69.4M | Sell |
|
|||||
|
2022
Q3 | $56.2M | Sell |
|
|||||
|
2022
Q2 | $61.6M | Sell |
|
|||||
|
2022
Q1 | $65.7M | Sell |
|
|||||
|
2021
Q4 | $83.4M | Buy |
|
|||||
|
2021
Q3 | $76.4M | Buy |
|
|||||
|
2021
Q2 | $74M | Buy |
|
|||||
|
2021
Q1 | $69.4M | Sell |
|
|||||
|
2020
Q4 | $74.4M | Sell |
|
|||||
|
2020
Q3 | $80.7M | Sell |
|
|||||
|
2020
Q2 | $132M | Buy |
|
|||||
|
2020
Q1 | $64.2M | Sell |
|
|||||
|
2019
Q4 | $57.3M | Sell |
|
|||||
|
2019
Q3 | $56.9M | Sell |
|
|||||
|
2019
Q2 | $61M | Sell |
|
|||||
|
2019
Q1 | $71.2M | Buy |
|
|||||
|
2018
Q4 | $64.2M | Buy |
|
|||||
|
2018
Q3 | $69.4M | Sell |
|
|||||
|
2018
Q2 | $65M | Sell |
|
|||||
|
2018
Q1 | $69.5M | Sell |
|
|||||
|
2017
Q4 | $67M | Sell |
|
|||||
|
2017
Q3 | $96.9M | Buy |
|
|||||
|
2017
Q2 | $70.1M | Sell |
|
|||||
|
2017
Q1 | $116M | Sell |
|
|||||
|
2016
Q4 | $174M | Sell |
|
|||||
|
2016
Q3 | $192M | Buy |
|
|||||
|
2016
Q2 | $197M | Sell |
|
|||||
|
2016
Q1 | $222M | Buy |
|
|||||
|
2015
Q4 | $203M | Buy |
|
|||||
|
2015
Q3 | $187M | Buy |
|
|||||
|
2015
Q2 | $216M | Buy |
|
|||||
|
2015
Q1 | $175M | Sell |
|
|||||
|
2014
Q4 | $169M | Buy |
|
|||||
|
2014
Q3 | $118M | Buy |
|
|||||
|
2014
Q2 | $91.4M | Sell |
|
|||||
|
2014
Q1 | $78.6M | Buy |
|
|||||
|
2013
Q4 | $82.2M | Sell |
|
|||||
|
2013
Q3 | $73.8M | Sell |
|
|||||
|
2013
Q2 | $69.6M | Buy |
|